A synthetic transcription platform for programmable gene expression in mammalian cells

Nat Commun. 2022 Oct 18;13(1):6167. doi: 10.1038/s41467-022-33287-9.

Abstract

Precise, scalable, and sustainable control of genetic and cellular activities in mammalian cells is key to developing precision therapeutics and smart biomanufacturing. Here we create a highly tunable, modular, versatile CRISPR-based synthetic transcription system for the programmable control of gene expression and cellular phenotypes in mammalian cells. Genetic circuits consisting of well-characterized libraries of guide RNAs, binding motifs of synthetic operators, transcriptional activators, and additional genetic regulatory elements express mammalian genes in a highly predictable and tunable manner. We demonstrate the programmable control of reporter genes episomally and chromosomally, with up to 25-fold more activity than seen with the EF1α promoter, in multiple cell types. We use these circuits to program the secretion of human monoclonal antibodies and to control T-cell effector function marked by interferon-γ production. Antibody titers and interferon-γ concentrations significantly correlate with synthetic promoter strengths, providing a platform for programming gene expression and cellular function in diverse applications.

Publication types

  • Research Support, U.S. Gov't, Non-P.H.S.
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antibodies, Monoclonal / genetics
  • Gene Expression
  • Gene Regulatory Networks
  • Humans
  • Interferon-gamma* / genetics
  • Mammals / genetics
  • Synthetic Biology
  • Transcription Factors* / metabolism
  • Transcription, Genetic

Substances

  • Interferon-gamma
  • Transcription Factors
  • Antibodies, Monoclonal